These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21604986)

  • 1. Vaccination for hepatitis C virus: closing in on an evasive target.
    Halliday J; Klenerman P; Barnes E
    Expert Rev Vaccines; 2011 May; 10(5):659-72. PubMed ID: 21604986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
    Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of vaccines for hepatitis C virus infection.
    Ghasemi F; Rostami S; Meshkat Z
    World J Gastroenterol; 2015 Nov; 21(42):11984-2002. PubMed ID: 26576087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C vaccine. Need of the hour.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(7):1927-9. PubMed ID: 25424801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
    Baumert TF; Fauvelle C; Chen DY; Lauer GM
    J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
    Beaumont E; Roingeard P
    Hum Vaccin Immunother; 2013 May; 9(5):1112-8. PubMed ID: 23406827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus vaccines among people who inject drugs.
    Cox AL; Thomas DL
    Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S46-50. PubMed ID: 23884065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
    Shi J; Li Y; Chang W; Zhang X; Wang FS
    Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-based immunity and vaccination against hepatitis C virus infection.
    Zhou Y; Zhang Y; Yao Z; Moorman JP; Jia Z
    Immunology; 2012 Aug; 136(4):385-96. PubMed ID: 22486354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.
    Guan J; Wen B; Deng Y; Zhang K; Chen H; Wu X; Ruan L; Tan W
    Virol J; 2011 Nov; 8():506. PubMed ID: 22054309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic vaccines against hepatitis C virus.
    Xue J; Zhu H; Chen Z
    Infect Genet Evol; 2014 Mar; 22():120-9. PubMed ID: 24462908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.
    Wada T; Kohara M; Yasutomi Y
    Vaccine; 2013 Dec; 31(50):5968-74. PubMed ID: 24144476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.
    Masavuli MG; Wijesundara DK; Underwood A; Christiansen D; Earnest-Silveira L; Bull R; Torresi J; Gowans EJ; Grubor-Bauk B
    Front Immunol; 2019; 10():1145. PubMed ID: 31178869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus.
    Pietschmann T; Brown RJP
    Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
    Singh R; Kaul R; Kaul A; Khan K
    World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
    Alvarez-Lajonchere L; Dueñas-Carrera S
    Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
    Ahlén G; Frelin L
    Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
    Zhang S; Bakshi RK; Suneetha PV; Fytili P; Antunes DA; Vieira GF; Jacobs R; Klade CS; Manns MP; Kraft AR; Wedemeyer H; Schlaphoff V; Cornberg M
    J Virol; 2015 Aug; 89(16):8304-17. PubMed ID: 26041301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.